Phillips Elizabeth D sold (to issuer) $181K of KEQU
Phillips Elizabeth D (SVP, People & Culture) sold (to issuer) 4,995 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.18M total) on 2026-06-30.
KEWAUNEE SCIENTIFIC CORP /DE/
No enriched coverage for $KEQU in the last 7 days.
No SEC Form 4 filings for $KEQU in the last 30 days.
See all $KEQU insider activity →Phillips Elizabeth D (SVP, People & Culture) sold (to issuer) 4,995 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.18M total) on 2026-06-30.
Noble Ryan S. (SVP, Sales & Marketing Dev) sold (to issuer) 3,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.11M total) on 2026-06-30.
Batdorff Douglas J. (SVP, Manufacturing Operations) sold (to issuer) 5,609 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.20M total) on 2026-06-30.
Recent KEQU coverage spans insider activity, financial news and earnings.
Routine insider sale to issuer (likely buyback participation) with no 10b5-1 plan disclosed; limited signal for fundamentals.
Routine insider sale to the issuer (buyback participation) with no 10b5-1 plan; likely limited signal value.
A routine insider sale to the issuer (buyback participation) with no 10b5-1 plan disclosed; likely limited signal value but can affect near-term sentiment.
Routine insider sale to the issuer (buyback participation) with no stated 10b5-1 plan; modest signal for near-term sentiment rather than fundamentals.
Routine insider sale to issuer (buyback participation) with no 10b5-1 plan stated; likely limited signal value but can affect near-term sentiment.
alphai scores every news story that mentions KEQU with an AI model for sentiment and relevance, and aggregates insider trades from KEWAUNEE SCIENTIFIC CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Phillips Elizabeth D (SVP, People & Culture) sold (to issuer) 4,995 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.18M total) on 2026-06-30.
2 min readNoble Ryan S. (SVP, Sales & Marketing Dev) sold (to issuer) 3,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.11M total) on 2026-06-30.
1 min readBatdorff Douglas J. (SVP, Manufacturing Operations) sold (to issuer) 5,609 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.20M total) on 2026-06-30.
2 min readGardner Donald T. III (Chief Financial Officer) sold (to issuer) 12,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.44M total) on 2026-06-30.
2 min readHULL THOMAS DAVID III (President & CEO) sold (to issuer) 17,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.62M total) on 2026-06-30.
2 min readKEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ
4 min readKewaunee Scientific (NASDAQ: KEQU) said it will release fourth-quarter and full-year results for the fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after market close, according to the company. The figures will be posted on its website after the announcement.
1 min readKewaunee Scientific (KEQU) reported a quarterly net other income/expense of -$978,000, representing a 0.31% year-over-year decline. The company, which specializes in laboratory furniture and equipment, traded at $36.73 with a market capitalization of $105.28 million as of May 2026. This update provides insights into the financial dynamics and market position of the NYSE-listed firm for US investors.
2 min readKewaunee Scientific Corporation (NASDAQ: KEQU) announced that it will release its third-quarter fiscal year 2026 financial results after market close on Wednesday, March 11, 2026. The results will be posted on the company's website and will include information on its expanded footprint, such as the Nu Aire acquisition and its multi-country manufacturing network. The announcement also highlighted the company's historical stock movement around earnings notice dates.
2 min readKewaunee Scientific Corporation announced it will release its third-quarter fiscal year 2026 financial results on Wednesday, March 11, 2026, after the close of trading, with information available on its website. The company, a global leader in laboratory and healthcare furniture, also highlighted its recent acquisition of Nu Aire, a manufacturer of essential laboratory products. The press release includes forward-looking statements and information about its risks and operations.
3 min read